Premier Research Group   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Workingham United Kingdom (2002)

Organization Overview

First Clinical Trial
2007
NCT00609466
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Premier Clinical Research | Premier Research Group - Austin | Premier Research Group Clinical Research Center | Premier Research Group (formerly SCIREX Corporation) | Premier Research Group Inc | Premier Research Group Limited | Premier Research Group Ltd. | Premier Research Group - Phoenix | Premier Research Group plc | Premier Research International LLC | Premier Research Labs

Active Ingredients

Drugs in Phase 4 Trials (7)

Key: Premier Research Group (5) Acquired (2)

adapalene (differin) (1 trial)

benzoyl peroxide (clearasil) (1 trial)

dexmethylphenidate (focalin) (3 trials)

levonorgestrel (3 trials)

pyridoxine (2 trials)

serdexmethylphenidate (AZSTARYS) (2 trials)

ulipristal (ella) (3 trials)

Drugs in Phase 3 Trials (42)

Key: Premier Research Group (31) Acquired (11)

acetaminophen (tylenol) (2 trials)

amisulpride (BARHEMSYS) (1 trial)

amniotic suspension (1 trial)

amphetamine (Adderall) (1 trial)

betamethasone (celestone) (1 trial)

brimonidine (alphagan) (2 trials)

calcipotriene (dovonex) (1 trial)

cantharidin (Ycanth) (5 trials)

celecoxib (celebrex) (3 trials)

codeine (Phenergan) (1 trial)

collagen (5 trials)

cyclobenzaprine (flexeril) (6 trials)

dexamethasone (1 trial)

diclofenac (voltaren) (3 trials)

Dimethylglycine (1 trial)

doxylamine (1 trial)

exenatide (byetta) (1 trial)

furosemide (lasix) (1 trial)

gentamicin (garamycin) (5 trials)

hydrochlorothiazide (esidrix) (2 trials)

hyrdrogen ion (1 trial)

ibuprofen (motrin) (4 trials)

immune globulin (human) (Gamastan) (1 trial)

indomethacin (indocin) (2 trials)

levobupivacaine (chirocaine) (8 trials)

losartan (cozaar) (2 trials)

meloxicam (mobic) (1 trial)

metronidazole (flagyl) (1 trial)

midazolam (versed) (2 trials)

minocycline (minocin) (2 trials)

morphine (2 trials)

nitrendipine (1 trial)

nonoxynol-9 (Delfen) (2 trials)

olmesartan (benicar) (3 trials)

ondansetron (zofran) (1 trial)

remimazolam (Byfavo) (2 trials)

ropivacaine (naropin) (1 trial)

saridegib (1 trial)

simufilam (2 trials)

tapentadol (nucynta) (1 trial)

Tiratricol (triacana) (1 trial)

tramadol (Ultram) (1 trial)

Drugs in Phase 2 Trials (28)

Key: Premier Research Group (16) Acquired (12)

99mtc ecdg (2 trials)

alfimeprase (1 trial)

anastrozole (arimidex) (1 trial)

bupivacaine (Exparel) (1 trial)

dimethandrolone undecanoate (2 trials)

ecopipam (1 trial)

estradiol (progynon depot) (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

fludeoxyglucose f-18 (2 trials)

fulvestrant (faslodex) (1 trial)

gft505 (1 trial)

lactobacillus fermentum (1 trial)

letrozole (femara) (1 trial)

levofloxacin (levaquin) (2 trials)

nitric oxide (inomax) (1 trial)

norgestrel (Ovral) (3 trials)

nyx-783 (1 trial)

pactimibe (1 trial)

rls-0071 (1 trial)

segesterone (Annovera) (4 trials)

somavaratan (2 trials)

sulforaphane (1 trial)

tamoxifen (nolvadex) (1 trial)

testosterone (delatestryl) (4 trials)

tetracycline (tetrex) (1 trial)

va111913 (1 trial)

varespladib methyl ester (2 trials)

verapamil (calan) (1 trial)

Drugs in Phase 1 Trials (6)

Key: Premier Research Group (4) Acquired (2)

11betamethyl nortestosterone dodecylcarbonate (2 trials)

99mtc ethylenedicysteine-deoxyglucose (1 trial)

candida albicans allergen (Candin) (1 trial)

tnx-2110 (1 trial)

tnx-2120 (1 trial)

tnx-2130 (1 trial)

Drugs in Other Trials (1)

b multivitamins (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Acute Pain (Phase 3)

Breast Neoplasms (Phase 2)

Bunion (Phase 3)

Childhood-Onset Fluency Disorder (Phase 2)

Communicable Diseases (Phase 3)

Diabetic Foot (Phase 2)

Disease (Phase 2)

Dwarfism, Pituitary (Phase 2)

Dysmenorrhea (Phase 2)

Endocrine System Diseases (Phase 2)

Erythema (Phase 3)

Facies (Phase 3)

Fatty Liver (Phase 2)

Fibromyalgia (Phase 3)

Foot Ulcer (Phase 2)

Hallux Valgus (Phase 3)

Hernia (Phase 2)

Hernia, Inguinal (Phase 2)

Immunologic Deficiency Syndromes (Phase 3)

Infections (Phase 3)

Molluscum Contagiosum (Phase 2)

Morning Sickness (Phase 4)

Myofascial Pain Syndromes (Phase 3)

Nausea (Phase 4)

Non-alcoholic Fatty Liver Disease (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Pain, Postoperative (Phase 3)

Pregnancy Complications (Phase 3)

Psoriasis (Phase 3)

Rosacea (Phase 3)

Stress Disorders, Post-Traumatic (Phase 3)

Stress Disorders, Traumatic (Phase 2)

Stuttering (Phase 2)

Surgical Wound (Phase 3)

Surgical Wound Infection (Phase 3)

Toothache (Phase 3)

Tooth, Impacted (Phase 3)

Ulcer (Phase 2)

Vomiting (Phase 4)

Wound Infection (Phase 3)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 104
  • # of Trial APIs: 84